SCHEMBL1033479

SCHEMBL1033479

CS(=O)(=O)c1cccc(-c2ccnc(NC3CCCCC3)n2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.55
CDK1 P06493 5/20 0.53
CCNB1 P14635 5/20 0.53
CCNB2 O95067 3/20 0.53
CCNB3 Q8WWL7 3/20 0.53
PTGS1 P23219 2/20 0.52
CDK4 P11802 2/20 0.50
CCNA2 P20248 2/20 0.50
CCND1 P24385 2/20 0.50
CDK2 P24941 2/20 0.50
CCNA1 P78396 2/20 0.50
IKBKB O14920 4/20 0.49
CDC7 O00311 1/20 0.48
PLK4 O00444 1/20 0.48
JAK2 O60674 1/20 0.48
MAP4K4 O95819 1/20 0.48
INSR P06213 1/20 0.48
CSF1R P07333 1/20 0.48
PIM1 P11309 1/20 0.48
PRKACA P17612 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1031156 0.87 ALDH1A1 (0.53) CDK1CCNB1CCNB2CCNB3IKBKB
SCHEMBL3748251 0.86 PTGS2 (0.69) PTGS2CDK1CCNB1CCNB2CCNB3
SCHEMBL1034510 0.85 IKBKB (0.57) IKBKBMAPK8MAPK9MAPK10
SCHEMBL1028968 0.80 MAP4K4 (0.55) CDK1CCNB1CCNB2CCNB3CDK4
SCHEMBL3619159 0.80 ADORA1 (0.59) CDK1CCNB1CCNB2CCNB3CCNA2
SCHEMBL1033626 0.80 CDK1 (0.53) CDK1CCNB1CCNB2CCNB3CDK4
SCHEMBL1030530 0.80 ADORA1 (0.59) CDK1CCNB1CCNB2CCNB3CCNA2
SCHEMBL1033986 0.79 PTK2 (0.49) CDK1CCNB1CCNB2CCNB3CDK4
SCHEMBL1033097 0.79 MKNK1 (0.57) CDK1CCNB1CCNB2CCNB3CDK4
SCHEMBL1032555 0.79 HDAC8 (0.47) CDK1CCNB1CCNB2CCNB3CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed